87 related articles for article (PubMed ID: 27487455)
1. Natural Compounds as Inhibitors of Tyrosyl-tRNA Synthetase.
Skupińska M; Stępniak P; Łętowska I; Rychlewski L; Barciszewska M; Barciszewski J; Giel-Pietraszuk M
Microb Drug Resist; 2017 Apr; 23(3):308-320. PubMed ID: 27487455
[TBL] [Abstract][Full Text] [Related]
2. Adenosine analogs as inhibitors of tyrosyl-tRNA synthetase: Design, synthesis and antibacterial evaluation.
Wei W; Shi WK; Wang PF; Zeng XT; Li P; Zhang JR; Li Q; Tang ZP; Peng J; Wu LZ; Xie MQ; Liu C; Li XH; Wang YC; Xiao ZP; Zhu HL
Bioorg Med Chem; 2015 Oct; 23(20):6602-11. PubMed ID: 26404408
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of adenosine containing 3-arylfuran-2(5H)-ones as tyrosyl-tRNA synthetase inhibitors.
Wei W; Liu Q; Li ZZ; Shi WK; Fu X; Liu J; Zhu X; Wang XC; Xu N; Li TF; Jiang FR; Xiao ZP; Zhu HL
Eur J Med Chem; 2017 Jun; 133():62-68. PubMed ID: 28380394
[TBL] [Abstract][Full Text] [Related]
4. Phenyltriazole-functionalized sulfamate inhibitors targeting tyrosyl- or isoleucyl-tRNA synthetase.
De Ruysscher D; Pang L; Mattelaer CA; Nautiyal M; De Graef S; Rozenski J; Strelkov SV; Lescrinier E; Weeks SD; Van Aerschot A
Bioorg Med Chem; 2020 Aug; 28(15):115580. PubMed ID: 32631562
[TBL] [Abstract][Full Text] [Related]
5. Tyrosyl-tRNA synthetase inhibitors: a patent review.
Sun J; Lv PC; Zhu HL
Expert Opin Ther Pat; 2017 May; 27(5):557-564. PubMed ID: 27977303
[TBL] [Abstract][Full Text] [Related]
6. Two Forms of Tyrosyl-tRNA Synthetase from
Hughes CA; Gorabi V; Escamilla Y; Dean FB; Bullard JM
SLAS Discov; 2020 Oct; 25(9):1072-1086. PubMed ID: 32583746
[No Abstract] [Full Text] [Related]
7. Metronidazole containing pyrazole derivatives potently inhibit tyrosyl-tRNA synthetase: design, synthesis, and biological evaluation.
Chen LW; Wang PF; Tang DJ; Tao XX; Man RJ; Qiu HY; Wang ZC; Xu C; Zhu HL
Chem Biol Drug Des; 2016 Oct; 88(4):592-8. PubMed ID: 27206529
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of new tyrosyl-tRNA synthetase inhibitors as antibacterial agents based on a N2-(arylacetyl)glycinanilide scaffold.
Xiao ZP; Wei W; Wang PF; Shi WK; Zhu N; Xie MQ; Sun YW; Li LX; Xie YX; Zhu LS; Tang N; Ouyang H; Li XH; Wang GC; Zhu HL
Eur J Med Chem; 2015 Sep; 102():631-8. PubMed ID: 26318069
[TBL] [Abstract][Full Text] [Related]
9. 4-alkoxy-3-arylfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
Xiao ZP; Ouyang H; Wang XD; Lv PC; Huang ZJ; Yu SR; Yi TF; Yang YL; Zhu HL
Bioorg Med Chem; 2011 Jul; 19(13):3884-91. PubMed ID: 21669535
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel dinitrobenzotrifluoride containing o-hydroxybenzylamine derivatives as potential antibacterial agents.
Li QS; Ni HJ; Yang Y; Lv XH; Ruan BF
Med Chem; 2015; 11(3):305-13. PubMed ID: 25219926
[TBL] [Abstract][Full Text] [Related]
11. Tyrosyl-tRNA synthetase inhibitors as antibacterial agents: synthesis, molecular docking and structure-activity relationship analysis of 3-aryl-4-arylaminofuran-2(5H)-ones.
Xiao ZP; Ma TW; Liao ML; Feng YT; Peng XC; Li JL; Li ZP; Wu Y; Luo Q; Deng Y; Liang X; Zhu HL
Eur J Med Chem; 2011 Oct; 46(10):4904-14. PubMed ID: 21856050
[TBL] [Abstract][Full Text] [Related]
12. 3-Aryl-4-acyloxyethoxyfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
Wang XD; Deng RC; Dong JJ; Peng ZY; Gao XM; Li ST; Lin WQ; Lu CL; Xiao ZP; Zhu HL
Bioorg Med Chem; 2013 Sep; 21(17):4914-22. PubMed ID: 23891164
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of bacterial tyrosyl tRNA synthetase: synthesis of carbocyclic analogues of the natural product SB-219383.
Jarvest RL; Berge JM; Houge-Frydrych CS; Mensah LM; O'Hanlon PJ; Pope AJ
Bioorg Med Chem Lett; 2001 Sep; 11(18):2499-502. PubMed ID: 11549455
[TBL] [Abstract][Full Text] [Related]
14. Confirmation of the antibacterial mode of action of SB-219383, a novel tyrosyl tRNA synthetase inhibitor from a Micromonospora sp.
Greenwood RC; Gentry DR
J Antibiot (Tokyo); 2002 Apr; 55(4):423-6. PubMed ID: 12061551
[TBL] [Abstract][Full Text] [Related]
15. Synthetic analogues of SB-219383. Novel C-glycosyl peptides as inhibitors of tyrosyl tRNA synthetase.
Brown P; Eggleston DS; Haltiwanger RC; Jarvest RL; Mensah L; O'Hanlon PJ; Pope AJ
Bioorg Med Chem Lett; 2001 Mar; 11(5):711-4. PubMed ID: 11266175
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structure, molecular docking, and structure-activity relationship analysis of enamines: 3-aryl-4-alkylaminofuran-2(5H)-ones as potential antibacterials.
Xiao ZP; He XB; Peng ZY; Xiong TJ; Peng J; Chen LH; Zhu HL
Bioorg Med Chem; 2011 Mar; 19(5):1571-9. PubMed ID: 21330140
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and molecular docking of salicylic acid derivatives containing metronidazole as a new class of antimicrobial agents.
Guo ZH; Yin Y; Wang C; Wang PF; Zhang XT; Wang ZC; Zhu HL
Bioorg Med Chem; 2015 Sep; 23(18):6148-56. PubMed ID: 26304108
[TBL] [Abstract][Full Text] [Related]
18. Potent synthetic inhibitors of tyrosyl tRNA synthetase derived from C-pyranosyl analogues of SB-219383.
Jarvest RL; Berge JM; Brown P; Hamprecht DW; McNair DJ; Mensah L; O'Hanlon PJ; Pope AJ
Bioorg Med Chem Lett; 2001 Mar; 11(5):715-8. PubMed ID: 11266176
[TBL] [Abstract][Full Text] [Related]
19. Natural product-derived quaternary ammonium compounds with potent antimicrobial activity.
Joyce MD; Jennings MC; Santiago CN; Fletcher MH; Wuest WM; Minbiole KP
J Antibiot (Tokyo); 2016 Apr; 69(4):344-7. PubMed ID: 26577453
[No Abstract] [Full Text] [Related]
20. Synthesis and activity of analogues of SB-219383: novel potent inhibitors of bacterial tyrosyl tRNA synthetase.
Berge JM; Broom NJ; Houge-Frydrych CS; Jarvest RL; Mensah L; McNair DJ; O'Hanlon PJ; Pope AJ; Rittenhouse S
J Antibiot (Tokyo); 2000 Nov; 53(11):1282-92. PubMed ID: 11213289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
